South Georgia Capital’s Ionis Pharmaceuticals IONS Stock Holding History

South Georgia Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$8K	Hold	200	–	–	0.02%	143
2015 Q2	$12K	Buy	+200	New	+$12.7K	0.02%	142
2015 Q1	–	Sell	-500	Closed	-$31K	–	211
2014 Q4	$31K	Hold	500	–	–	0.06%	95
2014 Q3	$19K	Buy	+500	New	+$17.7K	0.03%	118

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

South Georgia Capital's IONS Position: Q3 2015 in Review

South Georgia Capital held its Ionis Pharmaceuticals (IONS) position steady in Q3 2015 at 200 shares worth $8K. The position accounts for 0.02% of the portfolio, ranked #143.

South Georgia Capital first reported a position in IONS in Q3 2014 and has held it in 4 quarters since. The position peaked at $31K in Q4 2014. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

South Georgia Capital held 200 shares of Ionis Pharmaceuticals worth $8K as of Q3 2015.
South Georgia Capital left its Ionis Pharmaceuticals share count unchanged in Q3 2015.
Ionis Pharmaceuticals made up 0.02% of South Georgia Capital's portfolio in Q3 2015, its #143 holding.
South Georgia Capital first reported a position in Ionis Pharmaceuticals in Q3 2014 and has held it in 4 quarters since.
South Georgia Capital's Ionis Pharmaceuticals position peaked at $31K in Q4 2014.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on South Georgia Capital's 13F filing for Q3 2015, filed 10 Nov 2015.